Asian Pacific Journal of Cancer Prevention

  • 제15권1호
  • /
  • Pages.397-405
  • /
  • 2014
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Obesity Related Adipokines and Colorectal Cancer: A Review and Meta-Analysis

  • Joshi, Rakhi Kumari (Department of Preventive Medicine, Kangwon National University School of Medicine) ;
  • Lee, Sang-Ah (Department of Preventive Medicine, Kangwon National University School of Medicine)
  • 발행 : 2014.01.15
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Obesity has been considered as an important risk factor for the development of colorectal cancer (CRC), but the association has not been fully elucidated. Obesity is linked significantly to adipose tissue dysfunction and to alteration of adipokines in blood; in particular, obesity-induced inflammation is thought to be an important link between obesity and colorectal cancer. Based on epidemiological studies, we undertook a systematic review to understand the association of circulating levels of selected adipokines, including adiponectin, leptin, resistin, IL-6 and TNF-${\alpha}$, with the level of CRC risk. Most prospective studies suggested protective effects of adiponectin, but these were attenuated by body mass index (BMI) and waist circumference (WC) data in our meta-analysis. On the other hand, meta-analyses for leptin and CRC did not demonstrate any association, similar to the results of systematic review. Although it proved difficult to determine whether other selected adipokines (resistin, IL-6 and TNF-${\alpha}$) were related to CRC risk due to small number of reports, the present systematic review suggested a positive association with elevated resistin levels but null associations with IL-6 and TNF-${\alpha}$.

키워드

참고문헌

  1. Aleksandrova K, Boeing H, Jenab M, et al (2012). Leptin and soluble leptin receptor in risk of colorectal cancer in the European prospective investigation into cancer and nutrition cohort. Cancer Res, 72, 5328-37. https://doi.org/10.1158/0008-5472.CAN-12-0465
  2. Aleksandrova K, Boeing H, Jenab M, et al (2012). Total and high-molecular weight adiponectin and risk of colorectal cancer: the European prospective investigation into cancer and nutrition study. Carcinogenesis, 33, 1211-8. https://doi.org/10.1093/carcin/bgs133
  3. Aleksandrova K, Nimptsch K, Pischon T (2013). Influence of obesity and related metabolic alterations on colorectal cancer risk. Current nutrition reports, 2, 1-9. https://doi.org/10.1007/s13668-012-0036-9
  4. An W, Bai Y, Deng SX, et al (2012). Adiponectin levels in patients with colorectal cancer and adenoma: a metaanalysis. Eur J Cancer Prev, 21, 126-33. https://doi.org/10.1097/CEJ.0b013e32834c9b55
  5. Arpaci F, Yilmaz MI, Ozet A, et al (2002). Low serum leptin level in colon cancer patients without significant weight loss. Tumori, 88, 147-9.
  6. Barb D, Williams CJ, Neuwirth AK, Mantzoros CS (2007). Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am J Clin Nutr, 86, 858-66.
  7. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101. https://doi.org/10.2307/2533446
  8. Bokarewa M, Nagaev I, Dahlberg L, et al (2005). Resistin, an adipokine with potent proinflammatory properties. J Immunol, 174, 5789-95. https://doi.org/10.4049/jimmunol.174.9.5789
  9. Chan AT, Ogino S, Giovannucci EL, Fuchs CS (2011). Inflammatory markers are associated with risk of colorectal cancer and chemopreventive response to anti-inflammatory drugs. Gastroenterol, 140, 799-808. https://doi.org/10.1053/j.gastro.2010.11.041
  10. Chen MW, Ye S, Zhao LL, et al (2012). Association of plasma total and high-molecular-weight adiponectin with risk of colorectal cancer: an observational study in Chinese male. Med Oncol, 29, 3129-35. https://doi.org/10.1007/s12032-012-0280-2
  11. Cochran W (1954). The combination of estimates from different experiments. Biometrics, 10, 101-29. https://doi.org/10.2307/3001666
  12. Considine RV, Sinha MK, Heiman ML, et al (1996). Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med, 334, 292-5. https://doi.org/10.1056/NEJM199602013340503
  13. Cottam DR, Mattar SG, Barinas-Mitchell E, et al (2004). The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg, 14, 589-600. https://doi.org/10.1381/096089204323093345
  14. Dai Z, Xu YC, Niu L (2007). Obesity and colorectal cancer risk: a meta-analysis of cohort studies. World J Gastroenterol, 13, 4199-206.
  15. Danese E, Montagnana M, Minicozzi AM, et al (2012). The role of resistin in colorectal cancer. Clin Chim Acta, 413, 760-4. https://doi.org/10.1016/j.cca.2012.01.019
  16. Dersimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88. https://doi.org/10.1016/0197-2456(86)90046-2
  17. Eder K, Baffy N, Falus A, Fulop AK (2009). The major inflammatory mediator interleukin-6 and obesity. Inflamm Res, 58, 727-36. https://doi.org/10.1007/s00011-009-0060-4
  18. Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. https://doi.org/10.1136/bmj.315.7109.629
  19. Erarslan E, Turkay C, Koktener A, et al (2009). Association of visceral fat accumulation and adiponectin levels with colorectal neoplasia. Dig Dis Sci, 54, 862-8. https://doi.org/10.1007/s10620-008-0440-6
  20. Fantuzzi G (2005). Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol Pract, 115, 911-9. https://doi.org/10.1016/j.jaci.2005.02.023
  21. Fernandez-Real JM, Ricart W (2003). Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev, 24, 278-301. https://doi.org/10.1210/er.2002-0010
  22. Friedman JM, Halaas JL (1998). Leptin and the regulation of body weight in mammals. Nature, 395, 763-70. https://doi.org/10.1038/27376
  23. Fruhbeck G (2006). Intracellular signalling pathways activated by leptin. Biochem J, 393, 7-20. https://doi.org/10.1042/BJ20051578
  24. Gialamas SP, Petridou ET, Tseleni-Balafouta S, et al (2011). Serum adiponectin levels and tissue expression of adiponectin receptors are associated with risk, stage, and grade of colorectal cancer. Metabolism, 60, 1530-8. https://doi.org/10.1016/j.metabol.2011.03.020
  25. Gialamas SP, Sergentanis TN, Antonopoulos CN, et al (2013). Circulating leptin levels and risk of colorectal cancer and adenoma: a case-control study and meta-analysis. Cancer Causes Control, 24, 2129-41. https://doi.org/10.1007/s10552-013-0290-1
  26. Gonullu G, Kahraman H, Bedir A, et al (2010). Association between adiponectin, resistin, insulin resistance, and colorectal tumors. Int J Colorectal Dis, 25, 205-12. https://doi.org/10.1007/s00384-009-0828-6
  27. Gs HJ (2011). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [update March 2011]. The Cochrane Collabration 2011.
  28. Gulcelik MA, Colakoglu K, Dincer H, et al (2012). Associations between adiponectin and two different cancers: breast and colon. Asian Pac J Cancer Prev, 13, 395-8. https://doi.org/10.7314/APJCP.2012.13.1.395
  29. Gunter MJ, Hoover DR, Yu H, et al (2008). Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res, 68, 329-37. https://doi.org/10.1158/0008-5472.CAN-07-2946
  30. Heikkila K, Harris R, Lowe G, et al (2009). Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a metaanalysis. Cancer Causes Control, 20, 15-26. https://doi.org/10.1007/s10552-008-9212-z
  31. Ho GY, Wang T, Gunter MJ, et al (2012). Adipokines linking obesity with colorectal cancer risk in postmenopausal women. Cancer Res, 72, 3029-37. https://doi.org/10.1158/0008-5472.CAN-11-2771
  32. Il'yasova D, Colbert LH, Harris TB, et al (2005). Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev, 14, 2413-8. https://doi.org/10.1158/1055-9965.EPI-05-0316
  33. Kawanami D, Maemura K, Takeda N, et al (2004). Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokineendothelial cell interactions. Biochem Biophys Res Commun, 314, 415-9. https://doi.org/10.1016/j.bbrc.2003.12.104
  34. Kemik O, Sumer A, Kemik AS, et al (2010). The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer. World J Surg Oncol, 8, 85. https://doi.org/10.1186/1477-7819-8-85
  35. Kern PA, Ranganathan S, Li C, et al (2001). Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab, 280, 745-51.
  36. Knupfer H, Preiss R (2010). Serum interleukin-6 levels in colorectal cancer patients a summary of published results. Int J Colorectal Dis, 25, 135-40. https://doi.org/10.1007/s00384-009-0818-8
  37. Kubota N, Terauchi Y, Yamauchi T, et al (2002). Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem, 277, 25863-6. https://doi.org/10.1074/jbc.C200251200
  38. Kumada M, Kihara S, Ouchi N, et al (2004). Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation, 109, 2046-9. https://doi.org/10.1161/01.CIR.0000127953.98131.ED
  39. Kumor A, Daniel P, Pietruczuk M, Malecka-Panas E (2009). Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients. Int J Colorectal Dis, 24, 275-81. https://doi.org/10.1007/s00384-008-0605-y
  40. Larsson SC, Wolk A (2007). Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr, 86, 556-65.
  41. Lee S, Choe JW, Kim HK, Sung J (2011). High-sensitivity C-reactive protein and cancer. J Epidemiol, 21, 161-8. https://doi.org/10.2188/jea.JE20100128
  42. Lotem J, Sachs L (1998). Different mechanisms for suppression of apoptosis by cytokines and calcium mobilizing compounds. Proc Natl Acad Sci U S A, 95, 4601-6. https://doi.org/10.1073/pnas.95.8.4601
  43. Lukanova A, Soderberg S, Kaaks R, Jellum E, Stattin P (2006). Serum adiponectin is not associated with risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev, 15, 401-2. https://doi.org/10.1158/1055-9965.EPI-05-0836
  44. Mantel N & Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
  45. Moghaddam AA, Woodward M and Huxley R (2007). Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev, 16, 2533-47. https://doi.org/10.1158/1055-9965.EPI-07-0708
  46. Nagaev I & Smith U (2001). Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun, 285, 561-4. https://doi.org/10.1006/bbrc.2001.5173
  47. Nakajima TE, Yamada Y, Hamano T, et al (2010). Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. Cancer Sci, 101, 1286-91. https://doi.org/10.1111/j.1349-7006.2010.01518.x
  48. Ning Y, Wang L, Giovannucci EL (2010). A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obes Rev, 11, 19-30. https://doi.org/10.1111/j.1467-789X.2009.00613.x
  49. Otake S, Takeda H, Fujishima S, et al (2010). Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer. World J Gastroenterol, 16, 1252-7. https://doi.org/10.3748/wjg.v16.i10.1252
  50. Pais R, Silaghi H, Silaghi AC, et al (2009). Metabolic syndrome and risk of subsequent colorectal cancer. World J Gastroenterol, 15, 5141-8. https://doi.org/10.3748/wjg.15.5141
  51. Paz-Filho G, Lim EL, Wong ML, Licinio J (2011). Associations between adipokines and obesity-related cancer. Front Biosci (Landmark Ed), 16, 1634-50. https://doi.org/10.2741/3810
  52. Reilly MP, Lehrke M, Wolfe ML, et al (2005). Resistin is an inflammatory marker of atherosclerosis in humans. Circulation, 111, 932-9. https://doi.org/10.1161/01.CIR.0000155620.10387.43
  53. Roberts DL, Dive C, Renehan AG (2010). Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med, 61, 301-16. https://doi.org/10.1146/annurev.med.080708.082713
  54. Salageanu A, Tucureanu C, Lerescu L, et al (2010). Serum levels of adipokines resistin and leptin in patients with colon cancer. J Med Life, 3, 416-20.
  55. Sierra-Honigmann MR, Nath AK, Murakami C, et al (1998). Biological action of leptin as an angiogenic factor. Science, 281, 1683-6. https://doi.org/10.1126/science.281.5383.1683
  56. Simons PJ, van den Pangaart PS, van Roomen CP, Aerts JM, Boon L (2005). Cytokine-mediated modulation of leptin and adiponectin secretion during in vitro adipogenesis: evidence that tumor necrosis factor-alpha- and interleukin-1betatreated human preadipocytes are potent leptin producers. Cytokine, 32, 94-103. https://doi.org/10.1016/j.cyto.2005.08.003
  57. Stattin P, Lukanova A, Biessy C, et al (2004). Obesity and colon cancer: does leptin provide a link? Int J Cancer, 109, 149-52. https://doi.org/10.1002/ijc.11668
  58. Stattin P, Palmqvist R, Soderberg S, et al (2003). Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden. Oncol Rep, 10, 2015-21.
  59. Stocks T, Lukanova A, Johansson M, et al (2008). Components of the metabolic syndrome and colorectal cancer risk; a prospective study. Int J Obes (Lond), 32, 304-14. https://doi.org/10.1038/sj.ijo.0803713
  60. Tamakoshi K, Toyoshima H, Wakai K, et al (2005). Leptin is associated with an increased female colorectal cancer risk: a nested case-control study in Japan. Oncol, 68, 454-61. https://doi.org/10.1159/000086988
  61. Tilg H, Moschen AR (2006). Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature reviews Immunol, 6, 772-83. https://doi.org/10.1038/nri1937
  62. Touvier M, Fezeu L, Ahluwalia N, et al (2012). Pre-diagnostic levels of adiponectin and soluble vascular cell adhesion molecule-1 are associated with colorectal cancer risk. World J Gastroenterol, 18, 2805-12. https://doi.org/10.3748/wjg.v18.i22.2805
  63. Wei EK, Giovannucci E, Fuchs CS, et al (2005). Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst, 97, 1688-94. https://doi.org/10.1093/jnci/dji376
  64. Wolf AM, Wolf D, Rumpold H, et al (2004). Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun, 323, 630-5. https://doi.org/10.1016/j.bbrc.2004.08.145
  65. Xu XT, Xu Q, Tong JL, et al (2011). Meta-analysis: circulating adiponectin levels and risk of colorectal cancer and adenoma. J Dig Dis, 12, 234-44. https://doi.org/10.1111/j.1751-2980.2011.00504.x
  66. Yamauchi T, Kamon J, Minokoshi Y, et al (2002). Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med, 8, 1288-95. https://doi.org/10.1038/nm788
  67. Yokota T, Oritani K, Takahashi I, et al (2000). Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood, 96, 1723-32.

피인용 문헌

  1. Lack of any Prognostic Relationship between Adiponectin Receptor (Adipo R1/R2) Expression for Early/Advanced Stage Gastric Cancer vol.15, pp.11, 2014, https://doi.org/10.7314/APJCP.2014.15.11.4711
  2. Adiponectin Receptor 1 (ADIPOR1) rs1342387 Polymorphism and Risk of Cancer: a Meta-analysis vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7515
  3. Body Mass Index Effects on Risk of Ovarian Cancer: A Meta-Analysis vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7665
  4. Association of Adiponectin Receptor (Adipo-R1/-R2) Expression and Colorectal Cancer vol.15, pp.21, 2014, https://doi.org/10.7314/APJCP.2014.15.21.9385
  5. Obesity, adipokines and cancer: an update vol.83, pp.2, 2014, https://doi.org/10.1111/cen.12667
  6. Adipo-R1 and Adipo-R2 Expression in Colorectal Adenomas and Carcinomas vol.16, pp.1, 2015, https://doi.org/10.7314/APJCP.2015.16.1.367
  7. Obesity and Obese-related Chronic Low-grade Inflammation in Promotion of Colorectal Cancer Development vol.16, pp.10, 2015, https://doi.org/10.7314/APJCP.2015.16.10.4161
  8. Temporal Epidemiological Assessment of Colorectal Cancer Incidence and Mortality in East Kazakhstan, 2004-2013 vol.16, pp.15, 2015, https://doi.org/10.7314/APJCP.2015.16.15.6413
  9. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients vol.16, pp.16, 2015, https://doi.org/10.7314/APJCP.2015.16.16.6923
  10. Associations of Probiotics with Vitamin D and Leptin Receptors and their Effects on Colon Cancer vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.3621
  11. Insulin-like Growth Factor-1, IGF-binding Protein-3, C-peptide and Colorectal Cancer: a Case-control Study vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.3735
  12. Association between plasma adiponectin levels and colorectal cancer risk in women vol.26, pp.7, 2015, https://doi.org/10.1007/s10552-015-0590-8
  13. Circulating adiponectin levels and risk of endometrial cancer: Systematic review and meta-analysis vol.11, pp.6, 2016, https://doi.org/10.3892/etm.2016.3251
  14. Plasma Leptin Levels and Risk of Incident Cancer: Results from the Dallas Heart Study vol.11, pp.9, 2016, https://doi.org/10.1371/journal.pone.0162845
  15. Circulating adipokine levels and prognostic value in septic patients vol.13, pp.1, 2016, https://doi.org/10.1186/s12950-016-0138-z
  16. Association of Obesity-Related Metabolic Disruptions With Cancer Risk and Outcome vol.34, pp.35, 2016, https://doi.org/10.1200/JCO.2016.69.6187
  17. Carbohydrate intake, obesity, metabolic syndrome and cancer risk? A two-part systematic review and meta-analysis protocol to estimate attributability vol.6, pp.1, 2016, https://doi.org/10.1136/bmjopen-2015-009301
  18. Upregulation of the adipokine genes ADIPOR1 and SPP1 is related to poor survival outcomes in colorectal cancer vol.117, pp.8, 2018, https://doi.org/10.1002/jso.25078
  19. Polymorphisms in genes related to inflammation and obesity and colorectal adenoma risk vol.57, pp.10, 2018, https://doi.org/10.1002/mc.22842